跳至主要内容
临床试验/ACTRN12617000144314
ACTRN12617000144314撤回未知

A Single Blind, Parallel Group, Randomised Controlled Trial of Sterilid vs Honevo for the treatment of Blepharitis in adult participants.

Honeylab Ltd0 个研究点目标入组 30 人开始时间: 2017年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Equal to or greater than 16 years old at the time of enrolment.
  • Optometrist diagnosis of current chronic blepharitis.

排除标准

  • Requirement of any topical or systemic antibiotic for any ophthalmic indication.
  • Requirement of any topical or systemic corticosteroid for any ophthalmic indication.
  • Use of any systemic corticosteroid or antibiotic for any indication during the 14 days prior to enrolment.
  • Known or suspected allergy to honey, bees, glycerine, Sterilid (Registered Trademark) or Tea tree oil.
  • Any condition or issue which, at the investigators discretion may pose a safety risk or impact the validity of the study results.
  • Ocular surgery within the last 3 months or planned during the following 3 months.
  • Pregnant or breastfeeding.

研究者

发起方
Honeylab Ltd

相似试验